Best Practices
Advertisement
Danielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP, discusses her genomics session at the 50th Annual ONS Congress.
Veronica Brady, PhD, FNP-BC, BC-ADM, CDCES, FADCES, shares insights from her ONS Congress presentation on the topic.
Mayorga identified and evaluated incongruencies between documentation in clinical practice and fall-risk compliance.
Andrea Wagner McDonnell, MSN, RN, OCN, presented on the portal during the 50th Annual ONS Congress.
Melinda Mayorga, RN, BSN, OCN, shares insights from her research on fall prevention in outpatient cancer care.
Open-ended questions revealed that nurses prioritized improving their patients' sleep as a means of promoting their health.
It's critical for oncology nurses to ask patients certain questions about their morning and evening fatigue levels.
Learn how nurses can help patients understand what AR expression means for their disease and potential treatment options.
Learn what nurses should know about emerging research that challenges long-standing treatment norms.
The presentation focused on how ambulatory care models shape patient outcomes, nursing roles, and continuing education.
Heidi Haynes, MN, CRNP, OCN, of the Oncology Nursing Society Board of Directors, highlights the chapters and resources.
Oncology nurses need to be equipped to dispel common myths about smoking.
Learn how oncology nurses can offer education and smoking cessation resources to help patients reduce their risk.
Teresa Hagan Thomas, PhD, RN, shares key tips and advice for getting the most out of ONS Congress this spring.
Learn what oncology nurses should know about sarcopenia and why it's an increasingly recognized predictor of poor prognosis.
Proactive symptom management and patient education are essential, as treatment completion remains a challenge.
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
If patients who smoke understand the pathophysiology, they may be more open to difficult conversations about cessation.
The aim of the research was to assess the combination of epirubicin and mindfulness to treat negative psychological symptoms.
Patients with kidney cancer desire more involvement and shared decision-making with clinicians about their treatment options.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.